Skip to main content
Erschienen in: Osteoporosis International 7/2018

05.04.2018 | Original Article

Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations

verfasst von: S. W. Kim, N. Hong, Y. Rhee, Y.-C. Choi, H. Y. Shin, S. M. Kim

Erschienen in: Osteoporosis International | Ausgabe 7/2018

Einloggen, um Zugang zu erhalten

Abstract

Summary

Patients with osteomalacia often visit the neurology department with conditions mimicking other myopathies. We analyzed clinical features of osteomalacia patients who visited the neurology department. These patients frequently presented with hypocalcemia, hypovitaminosis D, and pain with less severe weakness. Osteomalacia should be considered when patients present with pain and weakness.

Introduction

Osteomalacia is a disease of bone metabolism; however, some patients with osteomalacia initially visit the neurology department. As these patients often complain of weakness and gait disturbance, osteomalacia can be confused with other myopathies. We analyzed the clinical features of patients with osteomalacia who visited the neurology department.

Methods

We retrospectively reviewed the medical records. Osteomalacia was diagnosed based on symptoms, laboratory features, and imaging results. We compared the characteristics of patients with osteomalacia who visited the neurology department with (1) those who did not visit the neurology department and (2) patients with idiopathic inflammatory myopathy.

Results

Eighteen patients with osteomalacia visited the neurology department (NR group). The common etiologies in the NR group included tumors or antiepileptic medication, whereas antiviral medication was the most common in patients who did not visit the neurology department (non-NR group). The NR group showed lower serum calcium (p = 0.004) and 25-hydroxyvitamin D (p = 0.006) levels than the non-NR group. When compared with patients with inflammatory myopathy, both groups showed proximal dominant weakness. However, pain was more common in osteomalacia than in myopathy (p = 0.008), and patients with osteomalacia showed brisk deep tendon reflex more often (p = 0.017). Serum calcium (p = 0.003) and phosphate (p < 0.001) levels were lower in osteomalacia than in myopathy.

Conclusions

It was not uncommon for patients with osteomalacia to visit the neurology department. The clinical presentation of these patients can be more complex owing the superimposed neurological disease and accompanying hypocalcemia. Osteomalacia should be considered when patients present with pain and weakness.
Literatur
1.
Zurück zum Zitat Bhan A, Rao AD, Rao DS (2010) Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin N Am 39:321–331CrossRef Bhan A, Rao AD, Rao DS (2010) Osteomalacia as a result of vitamin D deficiency. Endocrinol Metab Clin N Am 39:321–331CrossRef
2.
Zurück zum Zitat Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, Chen RC et al (2011) Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol 45:468–473CrossRefPubMed Girgis CM, Wong T, Ngu MC, Emmett L, Archer KA, Chen RC et al (2011) Hypophosphataemic osteomalacia in patients on adefovir dipivoxil. J Clin Gastroenterol 45:468–473CrossRefPubMed
3.
Zurück zum Zitat Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044CrossRefPubMed Minisola S, Peacock M, Fukumoto S, Cipriani C, Pepe J, Tella SH, Collins MT (2017) Tumour-induced osteomalacia. Nat Rev Dis Primers 3:17044CrossRefPubMed
4.
Zurück zum Zitat Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13:187–194CrossRefPubMed Pfeifer M, Begerow B, Minne HW (2002) Vitamin D and muscle function. Osteoporos Int 13:187–194CrossRefPubMed
6.
Zurück zum Zitat Smith R, Stern G (1969) Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 8:511–520CrossRefPubMed Smith R, Stern G (1969) Muscular weakness in osteomalacia and hyperparathyroidism. J Neurol Sci 8:511–520CrossRefPubMed
9.
Zurück zum Zitat Fukumoto S, Ozono K, Michigami T, Minagawa M, Okazaki R, Sugimoto T, Takeuchi Y, Matsumoto T (2015) Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society. Endocr J 62:665–671CrossRefPubMed Fukumoto S, Ozono K, Michigami T, Minagawa M, Okazaki R, Sugimoto T, Takeuchi Y, Matsumoto T (2015) Pathogenesis and diagnostic criteria for rickets and osteomalacia—proposal by an expert panel supported by Ministry of Health, Labour and Welfare, Japan, the Japanese Society for Bone and Mineral Research and the Japan Endocrine Society. Endocr J 62:665–671CrossRefPubMed
10.
Zurück zum Zitat RMC Trial Group (2009) Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 8:158–164CrossRef RMC Trial Group (2009) Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study. Lancet Neurol 8:158–164CrossRef
12.
Zurück zum Zitat Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713–735CrossRefPubMed Inker LA, Astor BC, Fox CH, Isakova T, Lash JP, Peralta CA, Kurella Tamura M, Feldman HI (2014) KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 63:713–735CrossRefPubMed
13.
Zurück zum Zitat Al-Said YA, Al-Rached HS, Al-Qahtani HA, Jan MM (2009) Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci 36:336–339CrossRefPubMed Al-Said YA, Al-Rached HS, Al-Qahtani HA, Jan MM (2009) Severe proximal myopathy with remarkable recovery after vitamin D treatment. Can J Neurol Sci 36:336–339CrossRefPubMed
14.
Zurück zum Zitat Ripellino P, Terazzi E, Bersano E, Cantello R (2013) Adult osteomalacia: a treatable cause of “fear of falling” gait. Neurology 80:2079CrossRefPubMed Ripellino P, Terazzi E, Bersano E, Cantello R (2013) Adult osteomalacia: a treatable cause of “fear of falling” gait. Neurology 80:2079CrossRefPubMed
15.
Zurück zum Zitat Ladha SS, Whitaker MD, Bosch EP (2006) Oncogenic osteomalacia: muscular weakness and multiple fractures. Neurology 67:364–365CrossRefPubMed Ladha SS, Whitaker MD, Bosch EP (2006) Oncogenic osteomalacia: muscular weakness and multiple fractures. Neurology 67:364–365CrossRefPubMed
16.
18.
Zurück zum Zitat Assenza G, Campana C, Tombini M, Cosimo Quattrocchi C, Giambattistelli F, Benvenga A, Pellegrino G, Assenza F, Vernieri F, di Lazzaro V (2013) Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs. Muscle Nerve 48:837–838CrossRefPubMed Assenza G, Campana C, Tombini M, Cosimo Quattrocchi C, Giambattistelli F, Benvenga A, Pellegrino G, Assenza F, Vernieri F, di Lazzaro V (2013) Osteomalacic myopathy: an uncommon side effect of antiepileptic drugs. Muscle Nerve 48:837–838CrossRefPubMed
19.
Zurück zum Zitat Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58:1369–1374CrossRefPubMed Valmadrid C, Voorhees C, Litt B, Schneyer CR (2001) Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy. Arch Neurol 58:1369–1374CrossRefPubMed
22.
Zurück zum Zitat Qari FA, Nasser TA (2013) Association between neurological and rheumatological manifestations in vitamin D deficiency and vitamin D levels. Pak J Med Sci 29:735–739CrossRef Qari FA, Nasser TA (2013) Association between neurological and rheumatological manifestations in vitamin D deficiency and vitamin D levels. Pak J Med Sci 29:735–739CrossRef
23.
Zurück zum Zitat Ishikawa T, Saito M, Morishita H, Watanabe I (1995) Effect of hypocalcemia on muscle in disorders of calcium metabolism. Acta Paediatr Jpn 37:367–369CrossRefPubMed Ishikawa T, Saito M, Morishita H, Watanabe I (1995) Effect of hypocalcemia on muscle in disorders of calcium metabolism. Acta Paediatr Jpn 37:367–369CrossRefPubMed
24.
Zurück zum Zitat Hirata D, Nagashima T, Saito S, Okazaki H, Kano S, Minota S (2002) Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis. Mod Rheumatol 12:186–189CrossRefPubMed Hirata D, Nagashima T, Saito S, Okazaki H, Kano S, Minota S (2002) Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis. Mod Rheumatol 12:186–189CrossRefPubMed
25.
26.
Zurück zum Zitat Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA (2004) Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 38:1002–1005CrossRefPubMed Ali FE, Al-Bustan MA, Al-Busairi WA, Al-Mulla FA (2004) Loss of seizure control due to anticonvulsant-induced hypocalcemia. Ann Pharmacother 38:1002–1005CrossRefPubMed
28.
29.
Zurück zum Zitat Schubert L, DeLuca HF (2010) Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500:157–161CrossRefPubMed Schubert L, DeLuca HF (2010) Hypophosphatemia is responsible for skeletal muscle weakness of vitamin D deficiency. Arch Biochem Biophys 500:157–161CrossRefPubMed
30.
Zurück zum Zitat Policepatil SM, Caplan RH, Dolan M (2012) Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 111:173–175PubMed Policepatil SM, Caplan RH, Dolan M (2012) Hypocalcemic myopathy secondary to hypoparathyroidism. WMJ 111:173–175PubMed
31.
Zurück zum Zitat Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419–424CrossRefPubMed Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Andersen H, Charles P, Eriksen EF (2000) Hypovitaminosis D myopathy without biochemical signs of osteomalacic bone involvement. Calcif Tissue Int 66:419–424CrossRefPubMed
32.
Zurück zum Zitat Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006CrossRefPubMed Bischoff-Ferrari HA, Dawson-Hughes B, Willett WC, Staehelin HB, Bazemore MG, Zee RY, Wong JB (2004) Effect of vitamin D on falls: a meta-analysis. JAMA 291:1999–2006CrossRefPubMed
33.
Zurück zum Zitat Skaria J, Katiyar B, Srivastava T, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58CrossRefPubMed Skaria J, Katiyar B, Srivastava T, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58CrossRefPubMed
34.
Zurück zum Zitat Skaria J, Katiyar BC, Srivastava TP, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58CrossRefPubMed Skaria J, Katiyar BC, Srivastava TP, Dube B (1975) Myopathy and neuropathy associated with osteomalacia. Acta Neurol Scand 51:37–58CrossRefPubMed
35.
Zurück zum Zitat Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW (2005) The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 6:341–346CrossRefPubMed Parsonage MJ, Wilkins EG, Snowden N, Issa BG, Savage MW (2005) The development of hypophosphataemic osteomalacia with myopathy in two patients with HIV infection receiving tenofovir therapy. HIV Med 6:341–346CrossRefPubMed
36.
Zurück zum Zitat Mateo L, Holgado S, Marinoso ML, Perez-Andres R, Bonjoch A, Romeu J et al (2016) Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients. Clin Rheumatol 35:1271–1279CrossRefPubMed Mateo L, Holgado S, Marinoso ML, Perez-Andres R, Bonjoch A, Romeu J et al (2016) Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients. Clin Rheumatol 35:1271–1279CrossRefPubMed
37.
Zurück zum Zitat Jeong HJ, Lee JM, Lee TH, Lee JY, Kim HB, Heo MH, Choi G, Chae JN, Kim JM, Kim SH, Kwon KY (2014) Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab 21:76–83CrossRefPubMedPubMedCentral Jeong HJ, Lee JM, Lee TH, Lee JY, Kim HB, Heo MH, Choi G, Chae JN, Kim JM, Kim SH, Kwon KY (2014) Two cases of hypophosphatemic osteomalacia after long-term low dose adefovir therapy in chronic hepatitis B and literature review. J Bone Metab 21:76–83CrossRefPubMedPubMedCentral
38.
Zurück zum Zitat Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95:519–523CrossRefPubMed Bingham CT, Fitzpatrick LA (1993) Noninvasive testing in the diagnosis of osteomalacia. Am J Med 95:519–523CrossRefPubMed
Metadaten
Titel
Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations
verfasst von
S. W. Kim
N. Hong
Y. Rhee
Y.-C. Choi
H. Y. Shin
S. M. Kim
Publikationsdatum
05.04.2018
Verlag
Springer London
Erschienen in
Osteoporosis International / Ausgabe 7/2018
Print ISSN: 0937-941X
Elektronische ISSN: 1433-2965
DOI
https://doi.org/10.1007/s00198-018-4501-1

Weitere Artikel der Ausgabe 7/2018

Osteoporosis International 7/2018 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.